E. Oomen - de Hoop

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

S. Sleijfer, J. Aerts, C. H. van der Leest, 2018, British Journal of Cancer.

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

R. Mathijssen, T. van Gelder, N. D. de Groot, 2019, Pharmaceutical Research.

CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients.

W. V. van IJcken, S. Sleijfer, A. Sieuwerts, 2022, European journal of cancer.

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

S. Sleijfer, J. Aerts, C. H. van der Leest, 2018, British Journal of Cancer.

Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.

S. Sleijfer, J. Aerts, R. Mathijssen, 2019, European journal of cancer.

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

S. Sleijfer, A. Jager, F. D. de Jongh, 2021, Frontiers in Oncology.

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

A. Dingemans, C. Pitz, E. de Vries, 2021, European Journal of Cancer.

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1

R. Mathijssen, R. V. van Schaik, S. Bins, 2023, Clinical Pharmacokinetics.